Yu J, Xu X, Griffin J, Mu Q, Ho R
Cancers (Basel). 2024; 16(16).
PMID: 39199565
PMC: 11352501.
DOI: 10.3390/cancers16162792.
Kawaguchi S, Kawahara K, Fujiwara Y, Ohnishi K, Pan C, Yano H
Cancer Immunol Immunother. 2022; 71(9):2127-2139.
PMID: 35044489
PMC: 9374624.
DOI: 10.1007/s00262-022-03149-w.
Rojas S, Oviedo N
DNA Repair (Amst). 2021; 103:103127.
PMID: 33990031
PMC: 8876969.
DOI: 10.1016/j.dnarep.2021.103127.
Barghouth P, Thiruvalluvan M, LeGro M, Oviedo N
Semin Cell Dev Biol. 2018; 87:145-159.
PMID: 29727725
PMC: 7039696.
DOI: 10.1016/j.semcdb.2018.04.013.
Guyot M, Hilmi C, Ambrosetti D, Merlano M, Lo Nigro C, Durivault J
Oncotarget. 2016; 8(6):9174-9188.
PMID: 27999187
PMC: 5354723.
DOI: 10.18632/oncotarget.13942.
ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2.
Picco V, Coste I, Giraud-Panis M, Renno T, Gilson E, Pages G
Oncotarget. 2016; 7(29):46615-46627.
PMID: 27366950
PMC: 5216822.
DOI: 10.18632/oncotarget.10316.
Regional signals in the planarian body guide stem cell fate in the presence of genomic instability.
Peiris T, Ramirez D, Barghouth P, Ofoha U, Davidian D, Weckerle F
Development. 2016; 143(10):1697-709.
PMID: 27013241
PMC: 4874482.
DOI: 10.1242/dev.131318.
Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.
Chernet B, Levin M
J Clin Exp Oncol. 2014; Suppl 1.
PMID: 25525610
PMC: 4267524.
DOI: 10.4172/2324-9110.S1-002.
The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.
Grepin R, Ambrosetti D, Marsaud A, Gastaud L, Amiel J, Pedeutour F
PLoS One. 2014; 9(3):e89449.
PMID: 24676409
PMC: 3968004.
DOI: 10.1371/journal.pone.0089449.
Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.
Essafi-Benkhadir K, Onesto C, Stebe E, Moroni C, Pages G
Mol Biol Cell. 2007; 18(11):4648-58.
PMID: 17855506
PMC: 2043565.
DOI: 10.1091/mbc.e07-06-0570.
Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding.
Villanueva R, Morales-Peza N, Castelan-Sanchez I, Garcia-Villa E, Tapia R, Cid-Arregui A
BMC Cancer. 2006; 6:218.
PMID: 16945153
PMC: 1574339.
DOI: 10.1186/1471-2407-6-218.
Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer.
Vitale S, Cambien B, Karimdjee B, Barthel R, Staccini P, Luci C
Gut. 2006; 56(3):365-72.
PMID: 16870716
PMC: 1856814.
DOI: 10.1136/gut.2005.088989.
In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer.
Jenkins D, Yu S, Hornig Y, Purchio T, Contag P
Clin Exp Metastasis. 2004; 20(8):745-56.
PMID: 14713108
DOI: 10.1023/b:clin.0000006817.25962.87.
Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis.
Marchetti S, Chazal M, Dubreuil A, Fischel J, Etienne M, Milano G
Br J Cancer. 2001; 85(3):439-45.
PMID: 11487278
PMC: 2364074.
DOI: 10.1054/bjoc.2001.1908.
Effects of immunization with tumor cells double transfected with interleukin-2 (IL-2) and interleukin-12 (IL-12) genes on artificial metastasis of colon26 cells in BALB/c mice.
Takada T, Kato K, Yagita H, Hamada H, Okumura K
Clin Exp Metastasis. 1999; 17(2):125-30.
PMID: 10411104
DOI: 10.1023/a:1006569317551.
Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene.
Iwanuma Y, Kato K, Yagita H, Okumura K
Cancer Immunol Immunother. 1995; 40(1):17-23.
PMID: 7828164
PMC: 11037788.
DOI: 10.1007/BF01517231.
Antigenic variation in cancer metastasis: immune escape versus immune control.
Schirrmacher V, Fogel M, Russmann E, Bosslet K, Altevogt P, Beck L
Cancer Metastasis Rev. 1982; 1(3):241-74.
PMID: 6985248
DOI: 10.1007/BF00046830.
An appraisal of in vivo assays of excised tumours.
Hill R
Br J Cancer Suppl. 1980; 4:230-9.
PMID: 6932930
PMC: 2149236.
Temperature-sensitive tumorigenicity of cells transformed by a mutant of Moloney sarcoma virus.
Klarlund J, FORCHHAMMER J
Proc Natl Acad Sci U S A. 1980; 77(3):1501-5.
PMID: 6929500
PMC: 348523.
DOI: 10.1073/pnas.77.3.1501.
Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice.
Donahoe P, Fuller Jr A, Scully R, Guy S, Budzik G
Ann Surg. 1981; 194(4):472-80.
PMID: 6895157
PMC: 1345325.
DOI: 10.1097/00000658-198110000-00010.